SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009260
Filing Date
2016-11-03
Accepted
2016-11-03 17:26:53
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20160930x10q.htm 10-Q 1453857
2 EX-31.1 tlog-20160930ex311ae30d9.htm EX-31.1 18154
3 EX-31.2 tlog-20160930ex312893323.htm EX-31.2 18196
4 EX-32.1 tlog-20160930ex3213ead07.htm EX-32.1 7746
5 EX-32.2 tlog-20160930ex3225771cd.htm EX-32.2 7568
  Complete submission text file 0001558370-16-009260.txt   6414531

Data Files

Seq Description Document Type Size
6 EX-101.INS tlog-20160930.xml EX-101.INS 1507752
7 EX-101.SCH tlog-20160930.xsd EX-101.SCH 38141
8 EX-101.CAL tlog-20160930_cal.xml EX-101.CAL 51181
9 EX-101.DEF tlog-20160930_def.xml EX-101.DEF 164800
10 EX-101.LAB tlog-20160930_lab.xml EX-101.LAB 424018
11 EX-101.PRE tlog-20160930_pre.xml EX-101.PRE 296498
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 161972895
SIC: 2834 Pharmaceutical Preparations